Obesity and the risk of psoriatic arthritis: a population-based study.

Annals of the Rheumatic Diseases
Thorvardur Jon LoveH Choi

Abstract

Obesity is associated with an increased risk of psoriasis; however, its potential impact on the risk of psoriatic arthritis (PsA) remains unclear. To evaluate the association between body mass index (BMI) and the risk of PsA among patients with psoriasis from the general population. The authors conducted a cohort study using data from The Health Improvement Network, an electronic medical records database representative of the UK general population, collected between 1995 and 2010. The exposure of interest was the first BMI measured after psoriasis diagnosis and endpoints were incident cases of physician-diagnosed PsA. The authors estimated the RR of PsA after adjusting for age, sex, and histories of trauma, smoking and alcohol consumption. Among 75,395 individuals with psoriasis (43% male, mean follow-up of 5 years, and mean age of 52 years), 976 developed PsA (incidence rate, 26.5 per 10,000 person-years). The PsA incidence rates increased with increasing BMI. Compared with psoriasis patients with BMI <25 kg/m(2), the RRs for developing PsA were 1.09 (0.93-1.28) for BMIs from 25.0 to 29.9, 1.22 (1.02-1.47) for BMIs from 30.0 to 34.9 and 1.48 (1.20-1.81) for BMIs ≥35.0. In our secondary analysis among all individuals, regardles...Continue Reading

References

Jun 16, 2004·Circulation·Luis A García RodríguezAntonio González-Pérez
Oct 14, 2004·Obesity Surgery·Guillermo Higa-SansoneRaul J Rosenthal
May 6, 2005·The New England Journal of Medicine·Michael P Schön, W-Henning Boehncke
Oct 4, 2005·Journal of the American Academy of Dermatology·Joel M GelfandTara Rolstad
Jan 19, 2006·Obesity Surgery·João Eduardo Marques Tavares de Menezes EttingerEdvaldo Fahel
Jun 8, 2006·Health and Quality of Life Outcomes·Monali J BhosleRajesh Balkrishnan
Jun 20, 2006·Medical Hypotheses·E A HammingaH B Thio
Sep 16, 2006·Current Rheumatology Reports·Lotus MallbrisMona Ståhle
Oct 27, 2006·Pharmacoepidemiology and Drug Safety·James D LewisBrian L Strom
May 2, 2007·Arthritis and Rheumatism·Jasvinder A SinghSiamak Noorbaloochi
Jul 21, 2007·International Journal of Cancer. Journal International Du Cancer·Fiona Bath-HextallRichard Hubbard
Aug 9, 2007·Cancer Causes & Control : CCC·Sengwee TohSonia Hernández-Díaz
Dec 26, 2008·Pharmacoepidemiology and Drug Safety·Gillian C Hall
Apr 22, 2009·Archives of Dermatology·Abrar A QureshiGary C Curhan
Aug 18, 2009·The Journal of Urology·Elisa Martín-MerinoClaus G Roehrborn
Feb 5, 2010·Pharmacoepidemiology and Drug Safety·Ana RuigómezLuis Alberto García Rodríguez
Jun 24, 2010·Annals of the Rheumatic Diseases·García RodríguezHyon K Choi
Jul 21, 2010·Archives of Dermatology·Razieh Soltani-ArabshahiGerald G Krueger
Jul 21, 2010·Archives of Dermatology·Alexis Ogdie, Joel M Gelfand
Jul 27, 2010·Journal of the American Academy of Dermatology·Eric W HosslerChris M Mowad
Nov 16, 2010·The British Journal of Dermatology·N M SeminaraJ M Gelfand

❮ Previous
Next ❯

Citations

Sep 20, 2012·Rheumatology·Anna RussolilloMatteo Nicola Dario Di Minno
Mar 16, 2013·Current Opinion in Rheumatology·Philip Mease
Nov 20, 2013·Clinical Rheumatology·Jane HsiehPetros Efthimiou
Jun 19, 2013·Annals of the Rheumatic Diseases·Matteo Nicola Dario Di MinnoUNKNOWN CaRRDs Study Group
Sep 6, 2013·Clinical Rheumatology·Francesco UrsiniRosa Daniela Grembiale
Dec 10, 2014·Best Practice & Research. Clinical Rheumatology·Andreas M Reimold, Vinod Chandran
Dec 3, 2014·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Héctor Romero-TalamásStacy Brethauer
Jan 7, 2016·Expert Review of Clinical Immunology·Muhammad Haroon, Oliver FitzGerald
Feb 22, 2014·Expert Opinion on Biological Therapy·Joshua E Weitz, Christopher T Ritchlin
Aug 6, 2014·Autoimmunity Reviews·Mathilde VersiniYehuda Shoenfeld
Jan 26, 2016·Autoimmunity Reviews·Florenzo IannoneGiovanni Lapadula
Apr 6, 2013·Journal of the Chinese Medical Association : JCMA·Hsi-Hsien LinChien-Lin Liu
Jun 5, 2013·Joint, Bone, Spine : Revue Du Rhumatisme·Charalampos PapagorasAlexandros A Drosos
Mar 13, 2016·Annales de dermatologie et de vénéréologie·C PhanUNKNOWN GEM Resopso
Oct 18, 2015·Rheumatic Diseases Clinics of North America·M Elaine Husni
Oct 18, 2015·Rheumatic Diseases Clinics of North America·Alexis Ogdie, Pamela Weiss
Oct 18, 2015·Rheumatic Diseases Clinics of North America·Jennifer L Barnas, Christopher T Ritchlin
Oct 18, 2015·Rheumatic Diseases Clinics of North America·Neil John McHugh
Jul 6, 2014·Journal of the European Academy of Dermatology and Venereology : JEADV·M-A RichardC Paul
Nov 26, 2013·The British Journal of Dermatology·W H BoehnckeA B Gottlieb
Mar 20, 2014·The British Journal of Dermatology·L NaldiUNKNOWN Psoriasis Emilia Romagna Study Group
Apr 9, 2014·Journal of the American Academy of Dermatology·Maya DebbanehWilson Liao
May 24, 2015·Autoimmunity Reviews·Kostas KakleasKyriaki Karavanaki
Aug 28, 2014·Frontiers in Immunology·Eric ToussirotGilles Dumoulin
Nov 27, 2014·Frontiers in Immunology·Elisa GremeseGianfranco Ferraccioli
May 26, 2016·Rheumatology International·Kaitlyn M Yim, April W Armstrong
Jun 4, 2016·Nature Reviews. Rheumatology·Shahla Abdollahi-RoodsazJose U Scher
Jul 9, 2016·Seminars in Arthritis and Rheumatism·Laura C CoatesCarle Paul
Aug 24, 2016·Expert Review of Clinical Immunology·Renata Baronaite Hansen, Arthur Kavanaugh
Dec 29, 2016·Arthritis & Rheumatology·Sebastian UnizonyHyon K Choi
May 12, 2017·Expert Review of Clinical Pharmacology·Santhi MantravadiWalter K Kraft
Jan 4, 2018·International Journal of Molecular Sciences·Lluís Puig
Jan 14, 2018·Calcified Tissue International·Ananta Paine, Christopher Ritchlin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.